425 related articles for article (PubMed ID: 25031730)
21. Latest advances in the pathological understanding of cholangiocarcinomas.
Nakanuma Y; Miyata T; Uchida T
Expert Rev Gastroenterol Hepatol; 2016; 10(1):113-27. PubMed ID: 26492529
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological Aspects and Diagnostic Problems in Patients with Intraductal Papillary Neoplasm of the Bile Duct.
Nanashima A; Imamura N; Sumida Y; Hiyoshi M; Hamada T; Nagayasu T
Anticancer Res; 2018 Apr; 38(4):2343-2352. PubMed ID: 29599359
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
Sasaki M; Sato Y
Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
[TBL] [Abstract][Full Text] [Related]
24. Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion.
Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Kato A; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Suda K; Takano S; Kondo Y; Miyazaki M
Am J Surg Pathol; 2011 Apr; 35(4):512-21. PubMed ID: 21412069
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study.
Kubota K; Jang JY; Nakanuma Y; Jang KT; Haruyama Y; Fukushima N; Furukawa T; Hong SM; Sakuraoka Y; Kim H; Matsumoto T; Lee KB; Zen Y; Kim J; Miyazaki M; Choi DW; Heo JS; Endo I; Hwang S; Nakamura M; Han HS; Uemoto S; Park SJ; Hong EK; Nanashima A; Kim DS; Kim JY; Ohta T; Kang KJ; Fukumoto T; Nah YW; Seo HI; Inui K; Yoon DS; Unno M
J Hepatobiliary Pancreat Sci; 2020 Sep; 27(9):581-597. PubMed ID: 32511838
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of Preoperative
Ikeno Y; Seo S; Yamamoto G; Nakamoto Y; Uemoto Y; Fuji H; Yoshino K; Yoh T; Taura K; Uemoto S
Anticancer Res; 2018 Jun; 38(6):3677-3682. PubMed ID: 29848727
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
Bickenbach K; Galka E; Roggin KK
Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
[TBL] [Abstract][Full Text] [Related]
28. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.
Lee S; Kim MJ; Kim S; Choi D; Jang KT; Park YN
J Hepatol; 2019 Apr; 70(4):692-699. PubMed ID: 30553839
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of surgery for 2010 WHO classification-based intraductal papillary neoplasm of the bile duct: Case-control study of a single Japanese institution's experience with special attention to mucin expression patterns.
Harada F; Matsuyama R; Mori R; Kumamoto T; Morioka D; Taguri M; Yamanaka S; Endo I
Eur J Surg Oncol; 2019 May; 45(5):761-768. PubMed ID: 30389302
[TBL] [Abstract][Full Text] [Related]
30. Pathological survey of precursor lesions in cholangiocarcinoma.
Nakanuma Y; Sugino T; Kakuda Y; Nomura Y; Watanabe H; Terada T; Sato Y; Ohnishi Y; Fukumura Y
J Hepatobiliary Pancreat Sci; 2023 Jul; 30(7):893-903. PubMed ID: 36707055
[TBL] [Abstract][Full Text] [Related]
31. Intraductal papillary neoplasm of the bile duct.
Wan XS; Xu YY; Qian JY; Yang XB; Wang AQ; He L; Zhao HT; Sang XT
World J Gastroenterol; 2013 Dec; 19(46):8595-604. PubMed ID: 24379576
[TBL] [Abstract][Full Text] [Related]
32. CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas.
Komori T; Inoue D; Zen Y; Yoneda N; Kitao A; Kozaka K; Yokka A; Toshima F; Matsubara T; Kobayashi S; Gabata T
Eur Radiol; 2019 Jun; 29(6):3132-3140. PubMed ID: 30519930
[TBL] [Abstract][Full Text] [Related]
33. Intraductal papillary neoplasm of the bile duct (IPNB): CT and MRI appearance with radiology-pathology correlation.
Aslam A; Wasnik AP; Shi J; Sahai V; Mendiratta-Lala M
Clin Imaging; 2020 Oct; 66():10-17. PubMed ID: 32438236
[TBL] [Abstract][Full Text] [Related]
34. Morphological classification of intraductal papillary neoplasm of the bile duct.
Ying S; Ying M; Liang W; Wang Z; Wang Q; Chen F; Xiao W
Eur Radiol; 2018 Apr; 28(4):1568-1578. PubMed ID: 29138880
[TBL] [Abstract][Full Text] [Related]
35. Cytomorphology of intraductal papillary neoplasm of the biliary tract.
Canepa M; Yao R; Nam GH; Patel NR; Pisharodi L
Diagn Cytopathol; 2019 Sep; 47(9):922-926. PubMed ID: 31116517
[TBL] [Abstract][Full Text] [Related]
36. Is a specific T classification needed for extrahepatic intraductal papillary neoplasm of the bile duct (IPNB) type 2 associated with invasive carcinoma?
Mitake Y; Onoe S; Igami T; Mizuno T; Yamaguchi J; Sunagawa M; Watanabe N; Kawakatsu S; Shimoyama Y; Ebata T
J Hepatobiliary Pancreat Sci; 2023 Jun; 30(6):745-754. PubMed ID: 36349508
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological Study of Resections of Intraductal Papillary Neoplasm of the Bile Duct.
Sato T; Hisaka T; Sakai H; Ishikawa H; Kawahara R; Goto Y; Nomura Y; Yasunaga M; Fujita F; Tanigawa M; Naito Y; Akiba J; Yano H; Tanaka H; Akagi Y; Okuda K
Anticancer Res; 2019 Aug; 39(8):4569-4573. PubMed ID: 31366561
[TBL] [Abstract][Full Text] [Related]
38. Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases.
Nakanuma Y; Xu J; Harada K; Sato Y; Sasaki M; Ikeda H; Kim J; Yu E
Pathol Int; 2011 May; 61(5):298-305. PubMed ID: 21501296
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the Clinicopathologic Characteristics of Intraductal Papillary Neoplasm of the Bile Duct according to Morphological and Anatomical Classifications.
Kim JR; Lee KB; Kwon W; Kim E; Kim SW; Jang JY
J Korean Med Sci; 2018 Oct; 33(42):e266. PubMed ID: 30310366
[TBL] [Abstract][Full Text] [Related]
40. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.
Goeppert B; Stichel D; Toth R; Fritzsche S; Loeffler MA; Schlitter AM; Neumann O; Assenov Y; Vogel MN; Mehrabi A; Hoffmann K; Köhler B; Springfeld C; Weichenhan D; Plass C; Esposito I; Schirmacher P; von Deimling A; Roessler S
Gut; 2022 Feb; 71(2):391-401. PubMed ID: 33468537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
